Margriet van der Heiden-van der Loo

Summary

Country: The Netherlands

Publications

  1. ncbi Introduction of sentinel node biopsy and stage migration of breast cancer
    M van der Heiden-van der Loo
    Comprehensive Cancer Centre Middle Netherlands, Postbus 19079, 3501 DB Utrecht, The Netherlands
    Eur J Surg Oncol 32:710-4. 2006
  2. ncbi [Percentage of local recurrence following treatment for breast cancer is not a suitable performance indicator]
    Margriet van der Heiden-van der Loo
    Integraal Kankercentrum Midden Nederland, Utrecht, The Netherlands
    Ned Tijdschr Geneeskd 154:A1984. 2010
  3. ncbi Variation between hospitals in surgical margins after first breast-conserving surgery in the Netherlands
    Margriet van der Heiden-van der Loo
    Department of Research, Comprehensive Cancer Centre the Netherlands, PO Box 19079, 3501 DB Utrecht, The Netherlands
    Breast Cancer Res Treat 131:691-8. 2012
  4. ncbi Implementation of sentinel node biopsy in breast cancer patients in the Netherlands
    Vincent K Y Ho
    Comprehensive Cancer Centre Middle Netherlands, Utrecht, The Netherlands
    Eur J Cancer 44:683-91. 2008

Detail Information

Publications4

  1. ncbi Introduction of sentinel node biopsy and stage migration of breast cancer
    M van der Heiden-van der Loo
    Comprehensive Cancer Centre Middle Netherlands, Postbus 19079, 3501 DB Utrecht, The Netherlands
    Eur J Surg Oncol 32:710-4. 2006
    ....
  2. ncbi [Percentage of local recurrence following treatment for breast cancer is not a suitable performance indicator]
    Margriet van der Heiden-van der Loo
    Integraal Kankercentrum Midden Nederland, Utrecht, The Netherlands
    Ned Tijdschr Geneeskd 154:A1984. 2010
    ..To describe the percentage of local recurrences within 5 years after surgery for breast cancer as a performance indicator for Dutch hospitals...
  3. ncbi Variation between hospitals in surgical margins after first breast-conserving surgery in the Netherlands
    Margriet van der Heiden-van der Loo
    Department of Research, Comprehensive Cancer Centre the Netherlands, PO Box 19079, 3501 DB Utrecht, The Netherlands
    Breast Cancer Res Treat 131:691-8. 2012
    ..The overall percentage of positive margins in the Netherlands is within the predefined targets. The variation between hospitals is substantial but can be largely explained by coincidence. Case mix correction leads to relevant shifts...
  4. ncbi Implementation of sentinel node biopsy in breast cancer patients in the Netherlands
    Vincent K Y Ho
    Comprehensive Cancer Centre Middle Netherlands, Utrecht, The Netherlands
    Eur J Cancer 44:683-91. 2008
    ..We examined the extent of use over time of SNB in women who were considered eligible for SNB on the basis of their clinical status...